Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma

JG Christensen, HY Zou, ME Arango, Q Li, JH Lee… - Molecular cancer …, 2007 - AACR
Abstract A t (2; 5) chromosomal translocation resulting in expression of an oncogenic kinase
fusion protein known as nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) has been …
被引用次数：782 相关文章
[PDF] academia.edu

[PDF][PDF] Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell …

JG Christensen, HY Zou, ME Arango, Q Li, JH Lee… - Mol Cancer …, 2007 - academia.edu
Abstract A t (2; 5) chromosomal translocation resulting in expression of an oncogenic kinase
fusion protein known as nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) has been …

Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma

JG Christensen, HY Zou, ME Arango… - Molecular cancer …, 2007 - pubmed.ncbi.nlm.nih.gov
A t (2; 5) chromosomal translocation resulting in expression of an oncogenic kinase fusion
protein known as nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) has been …

Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma.

JG Christensen, HY Zou, ME Arango, Q Li… - Molecular Cancer …, 2007 - europepmc.org
Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase
and c-Met, in experimental models of anaplastic large-cell lymphoma. - Abstract - Europe PMC …

Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma

JG Christensen, HY Zou, ME Arango, Q Li… - Molecular Cancer …, 2007 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> A t (2; 5) chromosomal translocation resulting
in expression of an oncogenic kinase fusion protein known as nucleophosmin-anaplastic …
[PDF] researchgate.net

[PDF][PDF] Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell …

JG Christensen, HY Zou, ME Arango, Q Li… - Mol Cancer …, 2007 - researchgate.net
Abstract A t (2; 5) chromosomal translocation resulting in expression of an oncogenic kinase
fusion protein known as nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) has been …
[PDF] academia.edu

[PDF][PDF] Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell …

JG Christensen, HY Zou, ME Arango, Q Li, JH Lee… - Mol Cancer …, 2007 - academia.edu
Abstract A t (2; 5) chromosomal translocation resulting in expression of an oncogenic kinase
fusion protein known as nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) has been …

[引用][C] Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell …

C JG - Mol Cancer Ther, 2007 - cir.nii.ac.jp
Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase
and c-Met, in experimental models of anaplastic large-cell lymphoma | CiNii Research CiNii …